Revolve Wealth Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Revolve Wealth Partners’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-498	Closed	-$201K	–	243
2024 Q4	$201K	Sell	498 -289	-37%	-$134K	0.03%	217
2024 Q3	$366K	Sell	787 -11	-1%	-$5.28K	0.06%	137
2024 Q2	$374K	Sell	798 -2	-0.3%	-$868	0.06%	119
2024 Q1	$334K	Buy	800 +26	+3%	+$11K	0.06%	123
2023 Q4	$315K	Buy	774 +17	+2%	+$6.28K	0.06%	119
2023 Q3	$263K	Sell	757 -2	-0.3%	-$699	0.06%	124
2023 Q2	$267K	Buy	759 +39	+5%	+$13.1K	0.06%	115
2023 Q1	$227K	Buy	720 +1	+0.1%	+$300	0.06%	129
2022 Q4	$208K	Buy	719 +27	+4%	+$8.23K	0.06%	136
2022 Q3	$200K	Sell	692 -57	-8%	-$16.4K	0.07%	125
2022 Q2	$211K	Buy	+749	New	+$200K	0.07%	128

Other funds holding VRTX

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return